Robert A. Sershon; Yale A. Fillingham; Arthur L. Malkani; Matthew P. Abdel; Ran Schwarzkopf; Douglas E. Padgett; Thomas P. Vail; Craig J. Della Valle; Afshin Anoushiravani; Stefano Bini; Erik Hansen; Michael Henne; Mathias Bostrom; Michael B. Cross; Tad L. Gerlinger; Denis Nam; Mark W. Pagnano; Kevin I. Perry
2021
The Journal of Arthroplasty, ISSN: 0883-5403, Vol: 36, Issue: 8, Page: 2921-2926
Oren I. Feder; David Yeroushalmi; Charles C. Lin; Matthew S. Galetta; Moretza Meftah; Claudette M. Lajam; James D. Slover; Ran Schwarzkopf; Joseph A. Bosco III; William B. Macaulay
2021
The Journal of Arthroplasty, ISSN: 0883-5403, Vol: 36, Issue: 8, Page: 2951-2956
Loef, Marieke; Gademan, Maaike G J; Latijnhouwers, Daisy A J M; Kroon, Herman M; Kaptijn, Herman H; Marijnissen, Willem J C M; Nelissen, Rob G H H; Vliet Vlieland, Thea P M; Kloppenburg, Margreet; LOAS Study Group
2021
The Journal of Arthroplasty, ISSN: 0883-5403, Vol: 36, Issue: 8, Page: 2779-2787.e4
Marc R. Angerame; Catie L. Eschen; Roseann M. Johnson; Jason M. Jennings; Douglas A. Dennis
2021
Background High-flexion total knee arthroplasty (HF-TKA) prostheses were designed with hopes of improving knee function. Studies have suggested increased failure with HF-TKAs. The purpose is to compare clinical results of HF-TKA versus conventional TKA (C-TKA) from the same implant system with long-term follow-up. Methods This review of prostheses implanted between 2004 and 2007 matched 145 of 179 possible HF-TKAs with 145 of 1347 possible C-TKAs. Mean follow-up was 121.5 ± 20.3 months. We were unable to match 12 HF-TKAs. HF-TKAs with less than 8-year follow-up were excluded. The primary outcome was failure requiring revision. Secondary outcomes included range of motion (ROM), Knee Society Scores (KSS), and radiolucent lines. Results In the matched cohort, there were 15 HF-TKA reoperations, 8 of which involved component revisions. There were 12 reoperations in the C-TKA cohort but no component revisions (P = .001). The analysis of the unmatched cohorts revealed a higher revision rate for HF-TKAs (P = .039) (HF-TKA: 10/179 vs C-TKA: 27/1347). At final follow-up, HF-TKAs exhibited more prosthesis radiolucent lines without evidence of loosening. Particularly, HF-TKAs demonstrated more femoral zone IV radiolucencies (38.7%) at final follow-up compared with C-TKAs (13.8%) (P < .001). There were no differences found between cohorts in ROM or KSS. Conclusion This study found an increased incidence of failure requiring revision with the HF-TKA in the matched and unmatched analyses. Higher incidences of radiolucent lines were found with HF-TKA. With no observed differences in ROM or KSS and a higher rate of failure with HF-TKA, there appears to be no advantage for use of the HF-TKA.
